Today: March 27, 2017, 2:46 am

Genzyme Corporation - Strategic SWOT Analysis Review - New Study Released

Fast Market Research recommends "Genzyme Corporation - Strategic SWOT Analysis Review" from GlobalData, now available 2014-03-01 16:39:41
Genzyme Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - GlobalData's summarization of the company's business strategy.
* SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.

Full Report Details at
- ..


Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. Its products and services focus on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. The company also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. It operates through two business units, namely, Rare Diseases division and Multiple Sclerosis division. Genzyme is a subsidiary of Sanofi and is headquartered in Massachusetts, the US.

Genzyme Corporation Key Recent Developments

Dec 16, 2013 Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases
May 01, 2013 FDA Reviewers Suggest Usage Of Filgrastim For Radiation Treatment
Apr 26, 2013 Genzyme's Matrix-induced Autologous Chondrocyte Implantation Receives Recommendation From EMA's CHMP
Feb 13, 2013 Sanofi To Invest EUR44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities

Reasons to Get this Report

* Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
* Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
* Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
* Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Genzyme Corporation - Key Facts
Genzyme Corporation - Key Employees
Genzyme Corporation - Key Employee Biographies
Genzyme Corporation - Major Products and Services
Genzyme Corporation - Pharmaceutical Pipeline Products Data
Genzyme Corporation, Pipeline Products by Therapy Area
Genzyme Corporation, Pipeline Products by Development Phase
Genzyme Corporation - History
Genzyme Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Genzyme Corporation - Key Manufacturing Facilities
Joint Venture
Section 2 - Company Analysis
Genzyme Corporation - Business Description
Genzyme Corporation - Corporate Strategy
Genzyme Corporation - SWOT Analysis
SWOT Analysis - Overview
Genzyme Corporation - Strengths
Strength - Strong Research and Development Activities
Strength - Synergy through Sanofi
Strength - Global Reach
Strength - Awards and Recognition
Genzyme Corporation - Weaknesses
Weakness - Patent Litigations
Weakness - Complete Response Letter on NDA Submission
Genzyme Corporation - Opportunities
Opportunity - New Market Approvals and Launches
Opportunity - Changing Demographics
Genzyme Corporation - Threats
Threat - Highly Competitive Industry
Threat - Lengthy Drug Approval Process
Threat - Increased Pricing Control
Threat - Emergence of Biogenerics / Biosimilars
Genzyme Corporation - Key Competitors
Section 3 - Company's Lifesciences Financial Deals and Alliances
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Genzyme Corporation, Recent Deals Summary
Section 4 - Company's Recent Developments
Genzyme Corporation, Recent Developments
Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases
May 01, 2013: FDA Reviewers Suggest Usage Of Filgrastim For Radiation Treatment
Apr 26, 2013: Genzyme's Matrix-induced Autologous Chondrocyte Implantation Receives Recommendation From EMA's CHMP
Feb 13, 2013: Sanofi To Invest EUR44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Section 5 - Appendix

Full Table of Contents is available at:

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 1002 Words
Related Articles
More From Health
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo [..]
PromarkerD Predictive Diagnostics for DKD to Roll-out [..]
PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader [..]
Do Prostalgene Drops Help To Restore Prostate [..]
Prostate enlargement is among the most common health problems for men over 50. With age the incidence of this condition [..]
Is OnycoSolve Spray The Key To Obliterating [..]
Toenail fungus is an undesirable but stubborn infection that comes with sweating, itching, cracking and scaling of the feet, inflammations, [..]
New Research reveals Asia poised as Preferred [..]
SYDNEY, Mar 10, 2017 - (ACN Newswire) - Frost & Sullivan has released its latest white paper, 'Asia: Preferred Destination for [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.